1,974 results match your criteria: "Artificial Urinary Sphincter"
World J Urol
December 2024
Division of Urology, Divisao de Clinica Urologica, School of Medicine, Hospital das Clinicas da Universidade de Sao Paulo, Avenida Dr. Eneas de Carvalho Aguiar, 255-Room 710F. 7th Floor, Sao Paulo, SP, CEP 05403-000, Brazil.
Purpose: Urethral instrumentation (UI) in patients with an artificial urinary sphincter (AUS) demands technical considerations and poses a risk of urethral erosion, leading to serious clinical and legal consequences. We conducted a national survey to evaluate the knowledge and experience of Brazilian urologists with UI in these patients.
Methods: This study used an electronic survey distributed to members of the Brazilian Society of Urology.
Arch Ital Urol Androl
October 2024
Department of Urology, Centre of Postgraduate Medical Education, Independent Public Hospital of Prof. W. Orlowski, Warsaw.
Purpose: To evaluate transperineal reanastomosis (TRPA) combined with incontinence surgery as a complex treatment for recurring vesicourethral anastomosis stenosis (VUAS) after radical prostatectomy (RP).
Methods: Retrospective analysis of 8 patients who underwent TRPA for recurring VUAS. Detailed preoperative and follow up data were assessed.
Urologia
December 2024
Urology Unit, Mater Dei Hospital, Bari, Italy.
Background: Vesicourethral anastomosis stenosis (VUAS) is a well-known complication of prostate cancer treatments, observed in up to 26% of the cases after radical prostatectomy. Conservative management, with single or even repeated transurethral dilation or endoscopic incision of the stenosis, is successful in many cases, but up to 9% of patients are destined to fail after endoscopic treatment. In these cases, a revision of the vesicourethral anastomosis is necessary and can be realized with different surgical approaches.
View Article and Find Full Text PDFWorld J Urol
December 2024
Neuro-Urology Unit, Department of Physical Medecine and Rehabilitation, Raymond Poincaré Hospital (APHP), UVSQ Paris, Saclay, UMR 1179, France.
Purpose: The artificial urinary sphincter (AUS) remains the gold standard to treat stress urinary incontinence related to sphincter insufficiency in patients with neurogenic lower urinary tract dysfunction (NLUTD). This study aims to assess the incidence of de novo neurogenic detrusor overactivity or low bladder compliance after AUS implantation in adult spinal cord injured patients.
Methods: Retrospective observational study, descriptive by analysis of the medical records of patients followed in a department of Neuro-Urology from January 01, 2003 to March 31, 2023.
Scand J Urol
December 2024
Department of Urology, Haukeland University Hospital, Bergen, Norway; Department of Clinical Medicine, University of Bergen, Bergen, Norway.
Objectives: To evaluate the efficacy of artificial urinary sphincter (AUS) implantation in men with stress urinary incontinence post-radical prostatectomy and the complication burden with a focus on identifying potential risk factors for reoperation as well as determining the fate of revision surgeries.
Methods: Retrospective analysis of consecutive patients undergoing primary AUS (pAUS) and revision AUS (rAUS) implantation at a tertiary centre. Logistic regression was employed to identify risk factors for reoperation associated with non-mechanical failures.
Aging Male
December 2025
Department of Urology, University Medical Center Hamburg-Eppendorf, Hamburg, Germany.
Purpose: This study evaluates the effectiveness of artificial urinary sphincter (AUS) implantation following transperineal reanastomosis in men with vesicourethral anastomotic stenosis (VUAS) and stress urinary incontinence (SUI) after radical prostatectomy (RP), focusing on long-term explantation rates and urinary continence.
Methods: Patients treated between 2009 and 2020 were retrospectively analyzed. Those undergoing AUS implantation post-transperineal reanastomosis for recurrent VUAS, excluding cases with prior pelvic irradiation and overactive bladder, were included.
A 65-year-old male patient with a history of external beam radiation therapy for prostate cancer and multiple urological surgeries developed a rectourethral fistula after treatment for urethral diverticulum with stones. In managing this complex case, a Penrose drain was utilized as a spacer during artificial urinary sphincter cuff removal to preserve the urethral space for future sphincter re-implantation. This report highlights the novel application of a Penrose drain as a spacer in urological surgery and its benefits in minimizing tissue contraction and preserving urethral health.
View Article and Find Full Text PDFStress urinary incontinence (SUI) significantly affects the quality of life in women, causing social, psychological, and physical distress. While artificial urinary sphincter (AUS) implantation is a well-established treatment for male incontinence, it is less commonly used in female patients and is typically considered for cases where other treatments have failed. This systematic review and meta-analysis aimed to evaluate the effectiveness and safety of AUS implantation in treating SUI in female patients, focusing on continence rates, revision rates, explant rates, and perioperative complications.
View Article and Find Full Text PDFUrology
December 2024
Department of Urology, Keck School of Medicine of the University of Southern, Los Angeles, CA. Electronic address:
Eur Urol
November 2024
Department of Urology, Section of Pelvic and Reconstructive Urology, Mayo Clinic, Rochester, MN, USA. Electronic address:
World J Urol
November 2024
Department of Urology, Sorbonne Université, AP-HP, Sorbonne Université, Pitié-Salpêtrière Academic Hospital, Assistance Publique-Hôpitaux de Paris, 75013, Paris, France.
Urology
November 2024
Department of Urology, University of Washington, Seattle, WA. Electronic address:
Curr Urol Rep
November 2024
Department of Urology, Indiana University, 11725 North Illinois Street - Carmel, Indianapolis, IN, IN - 46032, United States of America.
J Urol
November 2024
Department of Urology, Fox Chase Cancer Center, Philadelphia, Pennsylvania.
Urology
November 2024
Urology Service, Hospital del Trabajador, Santiago, Chile.
Transl Androl Urol
October 2024
AndroUrology Centre, Brisbane, QLD, Australia.
Transl Androl Urol
October 2024
Department of Urology, University Hospital of Tours, Tours, Loire Valley, France.
Transl Androl Urol
October 2024
Department of Urology, Mayo Clinic, Rochester, MN, USA.
World J Urol
November 2024
Department of Urology, Sorbonne University, Assistance Publique-Hôpitaux de Paris, Tenon Academic Hospital, Paris, France.
Minerva Urol Nephrol
November 2024
Institute for Health Research IdiPAZ, La Paz University Hospital, Madrid, Spain.
Urology
October 2024
University of Iowa Carver College of Medicine, Department of Urology, Iowa City, IA. Electronic address:
Objective: To assess a population-level perceived health status of common reconstructive urologic conditions using health utilities.
Methods: Health utilities are generic quality-of-life measures that can help describe overall health status and can quantitatively compare different disease states and the perceived benefits of various interventions. An a priori determined, representative sample of adult men were recruited by Qualtrics to review standardized scenarios describing typical patients with reconstructive urologic conditions, surgeries to treat conditions, and control conditions (eg, blindness, osteoarthritis).
Urology
October 2024
Keck School of Medicine of the University of Southern California, Department of Urology, Los Angeles, CA. Electronic address:
Objective: To assess risk of persistent opioid use and emergency department (ED) and office/outpatient visits following post-operative prescriptions of common opioids in patients following artificial urinary sphincter (AUS) implantation using a nationwide claims database.
Methods: The TriNetX US Collaborative Network, which encompasses over 115 million patients from 66 healthcare organizations was used to identify males who underwent first-time AUS placement between 2010-2024. Patients with history of opioid dependence/abuse, opioid use within 6 months prior to AUS placement, or surgery within 9 months post-operation were excluded.
J Urol
October 2024
Sorbonne Université, Service d'urologie, Hôpital Universitaire Pitié-Salpêtrière, AP-HP, Paris, France.
Purpose: Significant concerns remain regarding the long-term outcomes of AMS 800 artificial urinary sphincter (AUS) implants in men. The objective was to assess the long-term AUS reintervention (replacement or removal) rates after a first-ever AUS implantation.
Materials And Methods: This population-based retrospective cohort study included all men age ≥ 18 years in France who underwent a first-ever AUS implantation (identified using a unique device identifier) for male stress urinary incontinence (SUI) after prostate cancer (PCa) or benign prostatic hyperplasia (BPH) treatment, between January 1, 2006, and December 31, 2018.
Fr J Urol
October 2024
Department of Urology, Carémeau University Hospital, Nîmes, France.
Background: Stress urinary incontinence (SUI) is a public health issue, with major impact on quality of life. An efficient treatment for intrinsic sphincter deficiency (ISD) is the artificial urinary sphincter (AUS).
Objectives: Analyzing patient survival in terms of revision-free survival, removal-free survival and global survival without reintervention long-term results concerning continence status and complications.
World J Urol
October 2024
Department of Urology, University Hospital of Rennes, Rennes, France.
Purpose: Previous studies suggested better functional outcomes and longer device survival for female artificial urinary sphincter (AUS) implantation compared to male AUS implantation. We hypothesized that the adoption of robotic approaches for female implantation might have influenced these comparisons. This study aimed to compare the outcomes of robotic female AUS and male AUS implantation for non-neurogenic stress urinary incontinence (SUI).
View Article and Find Full Text PDF